ISBRA 2006 World Congress on Alcohol Research

Session Details

Targeting stressful neuroadaptations in the treatment of alcoholism

Tuesday, 12 September 2006 13:30 -15:00

Ballroom 3

Chair Markus Heilig NIAAA/NIHUnited States
Co-Chair Selena E Bartlett Ernest Gallo Clinic and Research Center, University of California San FranciscoUnited States

Role of Corticotrophin Releasing Factor (CRF) in NMDAR-Mediated Responses and Firing Rate of Ventral Tegmental Neurons
  • Antonello Bonci, UCSF/Gallo Center, United States
  • Corticotrophin releasing factor-binding protein (CRF-BP) as a novel target for the treatment of alcohol dependence
  • Selena E Bartlett, Ernest Gallo Clinic and Research Center, University of California San Francisco, United States
  • Validation Of CRH1 Receptors As A Treatment Target In Alcohol Dependence Using Alcohol Preferring msP Rats
  • Markus Heilig, NIAAA / NIH, United States
  • The Nociceptin/Orphanin FQ system is a potential target for new pharmacotreatment of alcohol abuse
  • Roberto Ciccocioppo, Italy
  • Metabotropic Glutamate Receptors as Potential Therapeutic Targets for the Treatment of Alcoholism
  • David L McKinzie, Lilly Neuroscience Research, Eli Lilly & Company, United States
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser